Cancer Biomarkers · 2019 · 40 citations · 26 references
Life SciencesMolecular BiologyOncologyGene ExpressionMolecular OncologyCancer BiomarkersExtracellular Vesicle SignalingMicrorna BiologyCirculating MicrornasExosomes In CancerExtracellular MicrornasExtracellular Vesicle BiomarkersMicrorna BiomarkersMicrorna In CancerMicrorna Prognostic MarkersNoninvasive Biomarkers
BACKGROUND: Increasing evidence have demonstrated that serum extracellular vesicle microRNAs (EV-miRNAs) are promising noninvasive biomarkers for various cancer types. OBJECTIVE: In this study, we aimed to investigate and evaluate the potential clinical significance of serum EV-miR-10b for acute myeloid leukemia (AML). METHODS: Blood samples were collected from a cohort of 95 de novo AML patients and 80 healthy individuals. Of all AML patients, 51 patients were considered as cytogenetic normal AML (CN-AML). Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) was performed to measure the expression levels of serum EV-miR-10b. RESULTS: The extracellular vesicles we extracted from the serum samples were positive for EV/exosome markers including TSG101, CD63, Flotillin-1 and CD9. The expression levels of serum EV-miR-10b were significantly higher in AML/CN-AML patients than healthy controls. In addition, serum EV-miR-10b expression was strongly correlated with aggressive clinical characteristics. Moreover, receiver operating characteristic analysis showed serum EV-miR-10b yielded an area under the curve of 0.875, with 77.89% specificity and 82.50% sensitivity in identifying AML patients from normal controls. Furthermore, AML patients with higher serum EV-miR-10b expression had significantly shorter survival and serum EV-miR-10b was demonstrated to be an independent prognostic marker for overall survival in AML. CONCLUSIONS: Taken together, serum EV-miR-10b might serve as a promising biomarker for predicting the prognosis of AML.
26
Bob Löwenberg, James R. Downing, Alan K. Burnett · New England Journal of Medicine · 1999 · 1.2K citations
Circulating Exosomal microRNAs as Biomarkers of Colon Cancer
Hiroko Ogata‐Kawata, Masashi Izumiya, Daisuke Kurioka et al. · PLoS ONE · 2014 · 802 citations · Full text
Mirosław J. Szczepański, Marta Szajnik, Anne Welsh et al. · Haematologica · 2011 · 413 citations · Full text
Life Sciences, Immunology, Oncology +15